Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,783 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
Daudén E, Griffiths CE, Ortonne JP, Kragballe K, Molta CT, Robertson D, Pedersen R, Estojak J, Boggs R. Daudén E, et al. Among authors: robertson d. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1374-82. doi: 10.1111/j.1468-3083.2009.03321.x. Epub 2009 Jun 26. J Eur Acad Dermatol Venereol. 2009. PMID: 19563497 Clinical Trial.
Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial.
Thaçi D, Galimberti R, Amaya-Guerra M, Rosenbach T, Robertson D, Pedersen R, Yang S, Kuligowski M, Boggs R. Thaçi D, et al. Among authors: robertson d. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):900-6. doi: 10.1111/jdv.12207. Epub 2013 Jul 15. J Eur Acad Dermatol Venereol. 2014. PMID: 23848989 Clinical Trial.
Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis.
Puig L, Strohal R, Husni ME, Tsai TF, Noppakun N, Szumski A, Yang S, Robertson D, Boggs R, Koenig AS. Puig L, et al. Among authors: robertson d. J Dermatolog Treat. 2015 Feb;26(1):7-15. doi: 10.3109/09546634.2013.860209. Epub 2013 Nov 27. J Dermatolog Treat. 2015. PMID: 24283931 Free article. Clinical Trial.
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
Strohal R, Puig L, Chouela E, Tsai TF, Melin J, Freundlich B, Molta CT, Fuiman J, Pedersen R, Robertson D. Strohal R, et al. Among authors: robertson d. J Dermatolog Treat. 2013 Jun;24(3):169-78. doi: 10.3109/09546634.2012.658015. Epub 2012 Feb 23. J Dermatolog Treat. 2013. PMID: 22251226 Free article. Clinical Trial.
3,783 results